Literature DB >> 14167821

AVAILABILITY OF TRITIATED THYMIDINE AFTER INTRAVENOUS ADMINISTRATION.

R N STAROSCIK, W H JENKINS, M L MENDELSOHN.   

Abstract

Entities:  

Keywords:  COLCHICINE; DNA; EXPERIMENTAL LAB STUDY; INJECTIONS, INTRAVENOUS; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RADIOAUTOGRAPHY; THYMIDINE; TRITIUM

Mesh：

Substances：

Year:  1964        PMID： 14167821     DOI： 10.1038/202456a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Endogenous versus exogenous markers of adult neurogenesis in canaries and other birds: advantages and disadvantages.

Authors:  Jacques Balthazart; Gregory F Ball
Journal:  J Comp Neurol       Date:  2014-08-20       Impact factor: 3.215

2.  The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice: labeling kinetics in vivo and clearance from blood serum.

Authors:  Dmitry I Maltsev; Kennelia A Mellanson; Vsevolod V Belousov; Grigori N Enikolopov; Oleg V Podgorny
Journal:  Histochem Cell Biol       Date:  2021-11-10       Impact factor: 4.304

3.  Flow cytometric determination of 5-bromo-2'-deoxyuridine pharmacokinetics in blood serum after intraperitoneal administration to rats and mice.

Authors:  Anna Matiašová; Juraj Sevc; Jaromír Mikeš; Rastislav Jendželovský; Zuzana Daxnerová; Peter Fedoročko
Journal:  Histochem Cell Biol       Date:  2014-07-25       Impact factor: 4.304

4.  The life cycle of antibody-forming cells. I. The generation time of 19S hemolytic plaque-forming cells during the primary and secondary responses.

Authors:  W J Tannenberg; A N Malaviya
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

5.  A new method for in vitro detection of bromodeoxyuridine in serum: a proof of concept in a songbird species, the canary.

Authors:  Jennifer M Barker; Thierry D Charlier; Gregory F Ball; Jacques Balthazart
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.